Primary pancreatic lymphoma:A case report and review of literature  

作　　者：Marko M Stojanovic Vesna Brzacki Goran Marjanovic Milica Nestorovic Jelena Zivadinovic Miljan Krstic Marko Gmijovic Ilija Golubovic Svetlana Jovanovic Miroslav P Stojanovic Katarina Terzic 

机构地区：[1]Department of Gastroenterology and Hepatology Clinic,University Clinical Center Nis,Medical Faculty University of Nis,Nis 18000,Serbia [2]Immunology,Medical Faculty University of Nis,Nis 18000,Serbia [3]Clinic for Digestive Surgery,University Clinical Center,Medical Faculty University of Nis,Nis 18000,Serbia [4]Clinic of Aneasthesiology and Intensive Therapy,University Clinical Center Nis,University of Nis,Nis 18000,Serbia [5]Department of Pathology,Medical Faculty University of Nis,Nis 18000,Serbia

出　　处：《World Journal of Clinical Oncology》2024年第11期1444-1453,共10页世界临床肿瘤学杂志（英文）

摘　　要：BACKGROUND Primary pancreatic lymphoma(PPL)is a rare tumor that mimics pancreatic adenocarcinoma,leading to diagnostic and therapeutic challenges.PPL accounts for 0.2%of all pancreatic tumors and is typically treated with chemotherapy.However,the long-term survival rates for PPL with chemotherapy and radiotherapy alone are unsatisfactory.Due to the improvements in pancreatic surgery,there is a need to reevaluate the treatment strategies for PPL.CASE SUMMARY A 62-year-old male presented to our clinic.A biopsy was unsuccessful,and the imaging was suggestive of pancreatic adenocarcinoma.Therefore,subtotal splenopancreatectomy was performed and histopathology was performed.He was then diagnosed with primary pancreatic diffuse large B-cell lymphoma.He received adjuvant chemotherapy and radiotherapy.Currently,the patient is alive with no evidence of disease 36 months after surgery.CONCLUSION The potential role of surgery in the treatment of PPL should be emphasized and added in the management protocol of early stage lymphoma.

关 键 词：LYMPHOMA PRIMARY PANCREAS Treatment STRATEGY SURGERY Case report 

分 类 号：R735.9[医药卫生—肿瘤]